Effects of herbal formula from Dillenia species extract for insomnia person: a double-blinded randomized controlled trial.

ational Innovation Agency (NIA) and Sciseeit.Co, Ltd.0 个研究点目标入组 80 人开始时间: 2023年7月11日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. Male or female with age from 18 to 70 years old
•2. Participants who diagnosed as insomnia by DSM-V assessment criteria.
•3. Patients who understand Thai language and be able to communicate with the research teams
•4. Participants who willing to participate the study

•1.Participants who experienced allergy to oleamide, Dillenia extract or other ingredients of the product.
•2.Pregnant or breastfeeding woman
•3.Patients who had an obstructive sleep apnea: OSA.
•4.Participant with abnormal liver function (AST, ALT > 3 times higher than normal).
•5.Participants with chronic kidney disease or acute kidney injury (GFR < 30 ml/min/1.73m2).
•6.Prticipant with BMI more than 30 (which is a risk to occur an OSA).
•7.Participants with other underlying diseases or medical problems that would interfere with the study such as a heart disease, schizophrenia, moderate to severe depression or anxiety that required treatment with other medications
•8.Participant who treating insomnia with other methods beside those prescribed in this study.
•9.Patients who are using medications or products that affect sleep quality (such as antianxiety, antihistamine, hemp, marijuana, amphetamine, stimulant, beta-blockers, steroids, theophylline etc.) 14 days before the study.

发起方

ational Innovation Agency (NIA) and Sciseeit.Co, Ltd.